Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: Need for better strategies

Journal of Infection

Volumn 42, Issue 2, 2001, Pages 120-125

  Malik, I ^a   Hussain, M ^a   Yousuf, H ^a  

^a National Cancer Institute   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CLOXACILLIN; FLUCONAZOLE; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN;

ADULT; AGE; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLEEDING; CANCER GROWTH; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL FEATURE; DEHYDRATION; DEMOGRAPHY; DIARRHEA; DYSPNEA; EVALUATION; FEBRILE NEUTROPENIA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION; INFORMATION PROCESSING; LIVER FUNCTION TEST; MALE; MEDICAL DOCUMENTATION; MENTAL DEFICIENCY; MONOTHERAPY; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; SEPSIS; SHOCK; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0034929994     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0798     Document Type: Article

References (24)

1. Management of fever in patients with cancer and treatment induced neutropenia
2. Infections in the cancer patient
3. Quantitative relationship between circulating leucocytes and infection in patients with acute leukemia
4. After empiric therapy: What to do until the granulocytes come back
5. Empiric antibacterial therapy in granulocytopenia induced by cancer chemotherapy
6. Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
7. The medical course of cancer patients with fever and neutropenia
8. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
9. A randomized trial coparing ceftazidime antibiotic therapy in cancer patients with fever and neutropenia
10. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients
11. A comparative study of imepenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with hematological malignancies
12. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer-A multicenter randomized trial
13. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients
14. Monotherapy for fever and neutropenia in cancer patients: A randomized comparison of ceftazidime versus imepenem
15. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in granulocytopenic patients with cancer
16. Randomized comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic patients
17. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: Metaanalysis
18. How should Imipenem-Cisplatin be used in the treatment of fever and infection in neurtopenic cancer patients?
19. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
20. Self-administered antibiotic therapy for chemotherapy-induced low-risk febrile neutropenia in patients with non-hematologic neoplasms
21. Out-patient management of febrile episodes in neutropenic cancer patients
22. Feasibility of out-patient management of fever in cancer patients with low-risk febrile neutropenia: Results of a prospective randomized trial
23. A pilot study of outpatient management of febrile neutropenic children with cancer at low-risk of bacteremia
24. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia